MedTrace Logo

AI Powered Mapping Technology for Identifying Arrhythmias

NCT06939478 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 112

Last updated 2026-05-22

No results posted yet for this study

Summary

Exploratory, hypothesis-generating study evaluating the impact of vMap on procedural efficiency, acute success, and work flow optimization.

Conditions

  • Arrhythmias, Cardiac

Interventions

DEVICE

Arrhythmia Mapping

vMap is indicated for analysis, display and storage of cardiac electrophysiological data and maps for analysis by a physician.

Sponsors & Collaborators

  • Vektor Medical

    collaborator INDUSTRY

  • Heart Rhythm Clinical and Research Solutions, LLC

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-27
Primary Completion
2026-03-05
Completion
2026-05-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06939478 on ClinicalTrials.gov